Cannabinoid receptor expression in estrogen-dependent and estrogen-independent endometrial cancer

References

• Lethaby A, Suckling J, Barlow D. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev. 2004;3:CD000402.
   PubMedGoogle Scholar
• Brinton LA, Trabert B, Anderson GL, et al. Serum estrogen and estrogen metabolites and endometrial cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2016;25:1081–1089.
   PubMed Web of Science ®Google Scholar
• Burke C. Endometrial cancer and tamoxifen. Clin J Oncol Nurs. 2005;9:247–249.
   PubMedGoogle Scholar
• Ulrich LS. Endometrial cancer, types, prognosis, female hormones and antihormones. Climacteric. 2011;14:418–425.
   PubMed Web of Science ®Google Scholar
• Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006;24:4783–4791.
   PubMed Web of Science ®Google Scholar
• Taylor CR, Cooper CL, Kurman RJ, et al. Detection of estrogen receptor in breast and endometrial carcinoma by the immunoperoxidase technique. Cancer. 1981;47:2634–2640.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ma XL, Xi CG, et al. Correlation between estrogen receptor status and clinicopathologic parameters in endometrial cancer: a comparative study by immunohistochemistry using different scoring systems. Chung-Hua Ping Li Hsueh Tsa Chih Chinese J Pathol. 2013;42:509–514.
   Google Scholar
• Dobrzycka B, Terlikowski SJ. Biomarkers as prognostic factors in endometrial cancer. Folia Histochem Cytobiol. 2010;48:319–322.
   PubMed Web of Science ®Google Scholar
• Guida M, Ligresti A, De Filippis D, et al. The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma. Endocrinology. 2010;151:921–928.
   PubMed Web of Science ®Google Scholar
• Fonseca BM, Correia-da-Silva G, Teixeira NA. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis. J Physiol Biochem. 2018;74:261–272.
   PubMed Web of Science ®Google Scholar
• Ayakannu T, Taylor AH, Willets JM. Validation of endogenous control reference genes for normalizing gene expression studies in endometrial carcinoma. Mol Hum Reprod. 2015;21:723–735.
   PubMed Web of Science ®Google Scholar
• Risinger JI, Maxwell GL, Chandramouli GVR, et al. Microaary analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res. 2003;63:6–11.
   PubMed Web of Science ®Google Scholar
• Mutch DG. The new FIGO staging system for cancers of the vulva, cervix, endometrium, and sarcomas. Gynecol Oncol.. 2009;115:325–328.
   Google Scholar
• Gebeh AK, Willets JM, Marczylo EL, et al. Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes. J Clin Endocrinol Metab. 2012;97:2827–2835.
   PubMed Web of Science ®Google Scholar
• Taylor AH, Abbas MS, Habiba MA, et al. Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle. Histochem Cell Biol. 2010;133:557–565.
   PubMed Web of Science ®Google Scholar
• Bakali E, Elliott RA, Taylor AH, et al. Distribution and function of the endocannabinoid system in the rat and human bladder. Int Urogynecol J. 2013;24:855–863.
   PubMed Web of Science ®Google Scholar
• Liu QR, Pan CH, Hishimoto A, et al. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav. 2009;8:519–530.
   PubMed Web of Science ®Google Scholar
• Taylor AH, Finney M, Lam PM, et al. Modulation of the endocannabinoid system in viable and non-viable first trimester pregnancies by pregnancy-related hormones. Reprod Biol Endocrinol. 2011;9:152.
   PubMed Web of Science ®Google Scholar
• Temkin SM, Minasian L, Noone A-M. The end of the hysterectomy epidemic and endometrial cancer incidence: What are the unintended cosequencesof declining hysterectomy rates? Front Oncol. 2016;6:89.
   PubMed Web of Science ®Google Scholar
• Cecyre B, Thomas S, Ptito M, et al. Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina. Naunyn-Schmiedeberg's Arch Pharmacol. 2014;387:175–184.
   Google Scholar
• Morozov YM, Dominguez MH, Varela L, et al. Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria. Eur J Neurosci. 2013;38:2341–2348.
   PubMed Web of Science ®Google Scholar
• El-Talatini MR, Taylor AH, Elson JC, et al. Localisation and function of the endocannabinoid system in the human ovary. PLoS One. 2009;4:e4579.
   PubMed Web of Science ®Google Scholar
• Habayeb OM, Taylor AH, Bell SC, et al. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology. 2008;149:5052–5060.
   PubMed Web of Science ®Google Scholar
• Van Dross R, Soliman E, Jha S, et al. Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth. Life Sci. 2013;92:463–466.
   PubMed Web of Science ®Google Scholar
• Carracedo A, Gironella M, Lorente M, et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res. 2006;66:6748–6755.
   PubMed Web of Science ®Google Scholar
• Klein Nulent TJW, Van Diest PJ, Van Der Groep P, et al. Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck. British J Oral Maxillofac Surg. 2013;51:604–609.
   PubMed Web of Science ®Google Scholar
• Chung SC, Hammarsten P, Josefsson A, et al. A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer. Eur J Cancer. 2009;45:174–182.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zou M, Baitei EY, et al. Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma. Cancer Gene Ther. 2008;15:101–107.
   PubMed Web of Science ®Google Scholar
• Cozzolino R, Calì G, Bifulco M, et al. A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. Invest New Drugs. 2010;28:115–123.
   PubMed Web of Science ®Google Scholar
• Gustafsson K, Wang X, Severa D, et al. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. Int J Cancer. 2008;123:1025–1033.
   PubMed Web of Science ®Google Scholar
• Michalski CW, Oti FE, Erkan M, et al. Cannabinoids in pancreatic cancer: Correlation with survival and pain. Int J Cancer. 2008;122:742–750.
   PubMed Web of Science ®Google Scholar
• Cudaback E, Marrs W, Moeller T, et al. The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS One 2010;5:e8702.
   PubMed Web of Science ®Google Scholar
• Wang DZ, Wang HB, Ning W, et al. Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res. 2008;68:6468–6476.
   PubMed Web of Science ®Google Scholar